Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil

Costa Clemens SA. et al, (2025), Mayo Clinic Proceedings Innovations Quality and Outcomes, 9

MetE: a promising protective antigen for tuberculosis vaccine development

Almujri SS. et al, (2025), Frontiers in Immunology, 16

Antibiotic use attributable to RSV infections during infancy - an international prospective birth cohort study

Hak SF. et al, (2025), Journal of Antimicrobial Chemotherapy, 80, 1803 - 1812

Load More